ImmunityBio, Inc.
Develops immunotherapies activating the immune system to fight cancer and infectious diseases.
IBRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 3530 JOHN HOPKINS COURT, 92121 SAN DIEGO
- Website:
- https://immunitybio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ImmunityBio, Inc. is a commercial-stage biotechnology company developing next-generation immunotherapies for cancers and infectious diseases. The company's core strategy is to strengthen the patient's own immune system by activating both its innate and adaptive branches, a comprehensive approach designed to orchestrate a coordinated attack on diseased cells and establish long-term immunological memory. Its clinical pipeline features therapies such as the IL-15 superagonist ANKTIVA®, engineered natural killer (NK) cell platforms, and adenovirus-vectored vaccines. These investigational treatments target a range of conditions, including various solid tumors like bladder and lung cancer, as well as infectious diseases such as HIV. ImmunityBio also provides its NK-92® cell line as a bioanalytical tool for research scientists.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ImmunityBio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ImmunityBio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ImmunityBio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
